Skip to content
Open access

P-360: Sustained continuous glucose monitoring engagement and glycemic improvement in a predominantly young socioeconomically vulnerable type 1 diabetes population

Nov 2026 · Hormone Research in Paediatrics · 0 citations

Abstract

Continuous glucose monitoring (CGM) improves glycemic control in type 1 diabetes (T1D), yet evidence from public health settings in socioeconomically vulnerable young populations remains scarce. To evaluate glycemic outcomes and user engagement with CGM in a predominantly young T1D population followed at a public health clinic in Northeastern Brazil. A 6-month longitudinal study enrolled 53 individuals with T1D. An intermittently scanned CGM device was used throughout follow-up. Glycated hemoglobin (HbA1c) was measured at baseline and at six months. Monthly CGM reports and questionnaires captured glycemic metrics and user behavior. A total of 32 (60.4%) of participants were under 25 years of age. The cohort was mostly self-declared Black or mixed-race (81.1%), with income up to 2 minimum wages (77.4%). HbA1c decreased from 9.7±1.19% to 7.9±1.86% over six months. In the under-25 group, baseline HbA1c was 9.08±1.92%, decreasing to 8.37±1.83% at six months. Across the full cohort, sensor active time was 80.7%, time in range 48.5%, and glucose management indicator 7.6%. Daily scans averaged 8.7, with near-universal nocturnal monitoring (95.9%). Median daily scan frequency differed across age groups: 6.6 in children under 12, 14.9 in adolescents, and 17.2 in adults aged 18-25 years. Most participants (77%) used CGM data to prevent hypoglycemia and 60.4% reported no discrepancy with capillary glucose at six months. Autonomy in scanning rose from 28.3% to 52.1%. Dermatitis was observed in approximately 15% of participants. A high-engagement group (active time equal to or above 70% and 8 or more scans/day) comprised 30.2% of participants. Continuous glucose monitoring promoted glycemic improvement and sustained engagement in a vulnerable population of predominantly young individuals with T1D, reinforcing the need for equitable access policies in public health systems.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.